Market Overview

Affirmed Therapeutics B.V. (NASDAQ: AFMD)

3.80 +0.10 (2.70%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.12
5.664M



Q4 2020
Pre-Market
EPS:
REV:
-0.21
4.331M



Q3 2020
Pre-Market
EPS:
REV:
-0.19
2.292M



Q2 2020
Pre-Market
EPS:
REV:
-0.19
4.489M
-0.16
5.52M
-0.18
3.231M
-12.5%
-41.47%
Q1 2020
Pre-Market
EPS:
REV:
0.03
12.715M
-0.14
5.93M
-0.12
5.664M
14.29%
-4.49%
Q4 2019
Pre-Market
EPS:
REV:
0.17
25.932M
-0.19
2.94M
-0.21
4.331M
-10.53%
47.31%
Q3 2019
Pre-Market
EPS:
REV:
-0.22
351.9K
-0.17
4.45M
-0.19
2.292M
-11.76%
-48.49%
Q2 2019
Pre-Market
EPS:
REV:
-0.15
174K
-0.14
3.97M
-0.19
4.489M
-35.71%
13.07%
Q1 2019
Pre-Market
EPS:
REV:
-0.18
633.08K
-0.17
3.61M
0.03
12.715M
117.65%
252.22%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!